Crystal structure of quinone reductase 2 in complex with cancer prodrug CB1954

Biochemical and Biophysical Research Communications

Volumn 336, Issue 1, 2005, Pages 332-338

  Fu, Yue ^a   Buryanovskyy, Leonid ^a   Zhang, Zhongtao ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

CB1954; Menadione; QR1; QR2; Quinone reductase; Substrate specificity

Indexed keywords

5 (1 AZIRIDINYL) 2,4 DINITROBENZAMIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ARTICLE; CRYSTAL STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ESCHERICHIA COLI; GENE MUTATION; HYDROGEN BOND; NONHUMAN; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; AZIRIDINES; CRYSTALLOGRAPHY; HUMANS; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PRODRUGS; QUINONE REDUCTASES;

ESCHERICHIA COLI;

EID: 24344493957     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.08.081     Document Type: Article

References (32)

1. S. Liao, and H.G. Williams-Ashmau Enzymatic oxidation of some nonphosphorylated derivatives of dihydronicotinamide Biochem. Biophys. Res. Commun. 4 1961 208 213
2. C.E. Foster, M.A. Bianchet, P. Talalay, Q. Zhao, and L.M. Amzel Crystal structure of human quinone reductase type 2, a metalloflavoprotein Biochemistry 38 1999 9881 9886
3. A.K. Jaiswal, P. Burnett, M. Adesnik, and O.W. McBride Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6 Biochemistry 29 1990 1899 1906
4. S. Harada, C. Fujii, A. Hayashi, and N. Ohkoshi An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2 Biochem. Biophys. Res. Commun. 288 2001 887 892
5. S. Harada, H. Tachikawa, and Y. Kawanishi A possible association between an insertion/deletion polymorphism of the NQO2 gene and schizophrenia Psychiatr. Genet. 13 2003 205 209
6. T. Okubo, S. Harada, S. Higuchi, and S. Matsushita Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms Alcohol Clin. Exp. Res. 27 2003 68S 71S
7. O. Ostrousky, S. Meged, R. Loewenthal, A. Valevski, A. Weizman, H. Carp, and E. Gazit NQO2 gene is associated with clozapine-induced agranulocytosis Tissue Antigens 62 2003 483 491
8. A.T. Dinkova-Kostova, and P. Talalay Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen Free Radic. Biol. Med. 29 2000 231 240
9. S. Chen, K. Wu, and R. Knox Structure-function studies of DT-diaphorase (NQO1) and NRH: quinone oxidoreductase (NQO2) Free Radic. Biol. Med. 29 2000 276 284
10. C.E. Foster, M.A. Bianchet, P. Talalay, M. Faig, and L.M. Amzel Structures of mammalian cytosolic quinone reductases Free Radic. Biol. Med. 29 2000 241 245
11. R.J. Knox, T.C. Jenkins, S.M. Hobbs, S. Chen, R.G. Melton, and P.J. Burke Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy Cancer Res. 60 2000 4179 4186
12. Q. Zhao, X.L. Yang, W.D. Holtzclaw, and P. Talalay Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase) Proc. Natl. Acad. Sci. USA 94 1997 1669 1674
13. L. Buryanovskyy, Y. Fu, M. Boyd, Y. Ma, T.C. Hsieh, J.M. Wu, and Z. Zhang Crystal structure of quinone reductase 2 in complex with resveratrol Biochemistry 43 2004 11417 11426
14. D.J. Long 2nd, A. Gaikwad, A. Multani, S. Pathak, C.A. Montgomery, F.J. Gonzalez, and A.K. Jaiswal Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia Cancer Res. 62 2002 3030 3036
15. D.J. Long 2nd, K. Iskander, A. Gaikwad, M. Arin, D.R. Roop, R. Knox, R. Barrios, and A.K. Jaiswal Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity J. Biol. Chem. 277 2002 46131 46139
16. W.A. Denny Nitroreductase-based GDEPT Curr. Pharm. Des. 8 2002 1349 1361
17. R.J. Knox, F. Friedlos, and M.P. Boland The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT) Cancer Metastasis Rev. 12 1993 195 212
18. G. Chung-Faye, D. Palmer, D. Anderson, J. Clark, M. Downes, J. Baddeley, S. Hussain, P.I. Murray, P. Searle, L. Seymour, P.A. Harris, D. Ferry, and D.J. Kerr Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954 Clin. Cancer Res. 7 2001 2662 2668
19. R.J. Knox, M.P. Boland, F. Friedlos, B. Coles, C. Southan, and J.J. Roberts The nitroreductase enzyme in Walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-yl)-4- hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2) Biochem. Pharmacol. 37 1988 4671 4677
20. Z. Wang, T.C. Hsieh, Z. Zhang, Y. Ma, and J.M. Wu Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography Biochem. Biophys. Res. Commun. 323 2004 743 749
21. Z. Otwinowski, and W. Minor J.R.M.S.C.W. Carter Methods in Enzymology 1997 Academic Press New York 307 326
22. A.T. Brunger, P.D. Adams, G.M. Clore, W.L. DeLano, P. Gros, R.W. Grosse-Kunstleve, J.S. Jiang, J. Kuszewski, M. Nilges, N.S. Pannu, R.J. Read, L.M. Rice, T. Simonson, and G.L. Warren Crystallography & NMR system: a new software suite for macromolecular structure determination Acta Crystallogr. D 54 Pt 5 1998 905 921
23. N. Guex, and M.C. Peitsch SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling Electrophoresis 18 1997 2714 2723
24. M. Harris, and T.A. Jones Molray-a web interface between O and the POV-Ray ray tracer Acta Crystallogr. D 57 2001 1201 1203
25. R.J. Knox, F. Friedlos, T. Marchbank, and J.J. Roberts Bioactivation of CB 1954: reaction of the active 4-hydroxylamino derivative with thioesters to form the ultimate DNA-DNA interstrand crosslinking species Biochem. Pharmacol. 42 1991 1691 1697
26. K. Wu, R. Knox, X.Z. Sun, P. Joseph, A.K. Jaiswal, D. Zhang, P.S. Deng, and S. Chen Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase Arch. Biochem. Biophys. 347 1997 221 228
27. R. Li, M.A. Bianchet, P. Talalay, and L.M. Amzel The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction Proc. Natl. Acad. Sci. USA 92 1995 8846 8850
28. J.A. Bridgewater, C.J. Springer, R.J. Knox, N.P. Minton, N.P. Michael, and M.K. Collins Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954 Eur. J. Cancer 31A 1995 2362 2370
29. N. Wakabayashi, A.T. Dinkova-Kostova, W.D. Holtzclaw, M.I. Kang, A. Kobayashi, M. Yamamoto, T.W. Kensler, and P. Talalay Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers Proc. Natl. Acad. Sci. USA 101 2004 2040 2045
30. M.P. Hay, R.F. Anderson, D.M. Ferry, W.R. Wilson, and W.A. Denny Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy J. Med. Chem. 46 2003 5533 5545
31. M.P. Hay, G.J. Atwell, W.R. Wilson, S.M. Pullen, and W.A. Denny Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase J. Med. Chem. 46 2003 2456 2466
32. N.A. Helsby, D.M. Ferry, A.V. Patterson, S.M. Pullen, and W.R. Wilson 2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT Br. J. Cancer 90 2004 1084 1092